Influenza, autoimmunity and atherogenesis

Autoimmunity Reviews

Volumn 4, Issue 2, 2005, Pages 101-105

  Gurevich, Victor S ^a  

^a NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

Author keywords

Atherosclerosis; Autoantibodies to oxidized LDL; Influenza; Molecular mimicry; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; GENERAL PRACTICE; HEART FAILURE; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INFLUENZA; ISCHEMIC HEART DISEASE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXIDATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RNA VIRUS INFECTION; THROMBOSIS; VACCINATION;

EID: 13844271119     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.10.006     Document Type: Review

References (40)

1. C.G. Fabricant, J. Fabricant, M.M. Litrenta, and C.R. Munick Virus-induced atherosclerosis J. Exp. Med. 148 1978 335 340
2. L.J. Jara, G. Medina, O. Vera-Lastra, and Y. Shoenfeld Atherosclerosis and antiphospholipid syndrome Clin. Rev. Allergy Immunol. 25 2003 79 88
3. H.E. Tillett, J.W. Smith, and C.D. Gooch Excess deaths attributable to influenza in England and Wales: age at death and certified cause Int. J. Epidemiol. 12 1983 344 352
4. S.S. Bondarenko, and F.A. Tumanov The effect of influenza and para-influenza on the course of ischemic heart disease Ter. Arkh. 64 1993 81 83
5. R. Vullers, B. Bultmann, H. Fischer, and O. Haferkamp Influenza a virus infection, a precipitating factor for the major heart attack Munch. Med. Wochenschr. 122 1980 1415 1417
6. M.S. Brown, and J.L. Goldstein Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis Ann. Rev. Biochem. 52 1983 223 261
7. T. Kodama, P. Reddy, C. Kishimoto, and M. Krieger Purification and characterization of a bovine acetyl low density lipoprotein receptor Proc. Natl. Acad. Sci. U. S. A. 85 1988 9238 9242
8. M. Krieger, and J. Herz Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP) Annu. Rev. Biochem. 63 1994 601 637
9. D. Steinberg, and J.L. Witztum Lipoproteins and atherogenesis: current concepts JAMA 264 1990 3047 3052
10. J.T. Salonen, S. Yla-Herttuala, R. Yamamotto, S. Butler, M. Korpela, and R. Salonen Autoantibody against oxidized LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
11. G.K. Hansson, J. Holm, and L. Jonasson Detection of activated T lymphocytes in the human atherosclerotic plaque Am. J. Pathol. 135 1989 169 175
12. A.C. Van der Wal, P. Das, D.B. Van de Berg, C.M. Van der Loo, and A.E. Becker Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response Lab. Invest. 61 1989 166 170
13. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 1876 1890
14. J. George, and Y. Shoenfeld Atherosclerosis as autoimmune disease Harefuah 129 1995 257 259
15. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus Arthritis Rheum. 39 1996 1466 1474
16. J. Frostegard Autoimmunity, oxidized LDL and cardiovascular disease Autoimmun. Rev. 4 2002 233 237
17. M.I. Azambuja, and B.B. Duncan Similarities in mortality patterns from influenza in the first half of the 20th century and the rise and fall of ischemic heart disease in the United States: a new hypothesis concerning the coronary heart disease epidemic Cad. Saude Publica 18 2002 557 577
18. M.I. Azambuja Spanish flu and early 20th-century expansion of a coronary heart disease-prone subpopulation Texas Heart Inst. J. 31 2004 14 21
19. W.R. Keatinge Winter mortality and its causes Int. J. Circumpolar Health 61 2002 292 299
20. A.W. Haider, M.G. Larson, C.J. O'Donnell, J.C. Evans, P.W. Wilson, and D. Levy The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study Am. J. Med. 106 1999 279 284
21. S. Hughes Novel cardiovascular risk factors J. Cardiovasc. Nurs. 18 2003 131 138
22. M. Madjid, I. Aboshady, I. Awan, S.W. Casscells, and Litovsky Influenza and cardiovascular disease: is there a causal relationship? Texas Heart Inst. J. 31 2004 4 13
23. E. Hak, T.J. Verheij, G.A. Van Essen, A.B. Lafeber, D.E. Grobbee, and A.W. Hoes Prognostic factors for influenza-associated hospitalization and death during an epidemic Epidemiol. Infect. 126 2001 261 268
24. A. Dvorakova, and R. Poledne Influenza-a trigger for acute myocardial infarction Atherosclerosis 172 2004 391 392
25. V.S. Gurevich, V.M. Pleskov, M.V. Levaia, A.I. Bannikov, L.B. Mitrofanova, and S.A. Urazgil'deeva Influenza virus infection in progressing atherosclerosis Kardiologia 42 2002 21 24
26. E. Engblom, T.O. Ekfors, O.H. Meurman, A. Toivanen, and J. Nikoskelainen Fatal influenza a myocarditis with isolation of virus from the myocardium Acta Med. Scand. 213 1983 75 78
27. A. Caton, D.M. Cerasoli, and F.F. Shih Immune recognition of influenza hemagglutinin as a viral and a neo-self-antigen Immunol. Res. 17 1998 23 32
28. A.J. Reed, M.P. Riley, and A.J. Caton Virus-induced maturation and activation of autoreactive memory B cells J. Exp. Med. 192 2000 1763 1774
29. B.J. Van Lenten, A.C. Wagner, G.M. Anantharamaiah, D.W. Garber, M.C. Fishbein, and L. Adhikary Influenza infection promotes macrophage traffic into arteries of mice. That is prevented by D-4F, an apolipoprotein A-I mimetic peptide Circulation 106 2002 1127 1132
30. J.J. Bouwman, F.L. Visseren, M.C. Bosch, K.P. Bouter, and R.J. Diepersloot Procoagulant and inflammatory response of virus-infected monocytes Eur. J. Clin. Investig. 32 2002 759 766
31. V. Gurevich, V. Pleskov, S. Urazgildeeva, L. Shatilina, L. Vasina, and L. Mitrofanova The role of immune response to influenza virus in progression of atherosclerosis Clin. Exp. Rheumatol. 22 13 2004 47
32. A.N. Klimov, V.S. Gurevich, A.A. Nikiforova, L.V. Shatilina, A.A. Kuzmin, and S.L. Plavinsky Antioxidative activity of high density lipoproteins in vivo Atherosclerosis 100 1993 13 18
33. M. Navab, J.A. Berliner, G. Subbanagounder, S. Hama, A.J. Lusis, and L.W. Castellani HDL and the inflammatory response induced by LDL-derived oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 21 2001 481 488
34. M. Naghavi, Z. Barlas, S. Siadaty, S. Naguib, M. Madjid, and W. Casscells Association of influenza vaccination and reduced risk of recurrent myocardial infarction Circulation 102 2000 3039 3045
35. E. Gurfinkel, and R.L. de La Fuente Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry Tex. Heart Inst. J. 31 2004 28 32
36. L.A. Jackson, O. Yu, S.R. Heckbert, B.M. Psaty, D. Malais, and W.E. Barlow Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events Am. J. Epidemiol. 156 2002 634 640
37. O. Ritter, A. Bonz, J. Strotmann, and H. Langenfeld Myocardial infarction after influenza vaccination Z. Kardiol. 92 2003 962 965
38. M.R. Geier, D.A. Geier, and A.C. Zahalsky Influenza vaccination and Guillain Barre syndrome small star, filled Clin. Immunol. 107 2003 116 121
39. E. Plotkin, J. Bernheim, S. Ben-Chetrit, A. Mor, and Z. Korzets Influenza vaccine-a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate Nephrol. Dial. Transplant. 15 2000 740 741
40. B. Chazan, R. Weiss, H. Tabenkin, M. Mines, and R. Raz Influenza vaccine does not produce myopathy in patients taking statins J. Fam. Pract. 51 2002 986 988